Cargando…
Chemovirotherapy: combining chemotherapeutic treatment with oncolytic virotherapy
Oncolytic virotherapy has made significant progress in recent years, however, widespread approval of virotherapeutics is still limited. Primarily, this is due to the fact that currently available virotherapeutics are mostly tested in monotherapeutic clinical trials exclusively (ie, not in combinatio...
Autores principales: | Binz, Eike, Lauer, Ulrich M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918378/ https://www.ncbi.nlm.nih.gov/pubmed/27512669 http://dx.doi.org/10.2147/OV.S54780 |
Ejemplares similares
-
Chemovirotherapy of Pancreatic Adenocarcinoma by Combining Oncolytic Vaccinia Virus GLV-1h68 with nab-Paclitaxel Plus Gemcitabine
por: Binz, Eike, et al.
Publicado: (2017) -
Chemovirotherapy of Lung Squamous Cell Carcinoma by Combining Oncolytic Adenovirus With Gemcitabine
por: Liu, Xing, et al.
Publicado: (2020) -
MicroRNA-sensitive oncolytic measles virus for chemovirotherapy of pancreatic cancer
por: Singh, Hans Martin, et al.
Publicado: (2021) -
ONCOLYTIC VIROTHERAPY
por: Russell, Stephen J, et al.
Publicado: (2012) -
Oncolytic Virotherapy with Myxoma Virus
por: Rahman, Masmudur M., et al.
Publicado: (2020)